134 related articles for article (PubMed ID: 30346082)
1. The antitumour growth and antiangiogenesis effects of xanthatin in murine glioma dynamically evaluated by dynamic contrast-enhanced magnetic resonance imaging.
Bi SX; Li XH; Wei CS; Xiang HH; Shen YX; Yu YQ
Phytother Res; 2019 Jan; 33(1):149-158. PubMed ID: 30346082
[TBL] [Abstract][Full Text] [Related]
2. Xanthatin induces glioma cell apoptosis and inhibits tumor growth via activating endoplasmic reticulum stress-dependent CHOP pathway.
Ma YY; Di ZM; Cao Q; Xu WS; Bi SX; Yu JS; Shen YJ; Yu YQ; Shen YX; Feng LJ
Acta Pharmacol Sin; 2020 Mar; 41(3):404-414. PubMed ID: 31700088
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.
Xuesong D; Wei X; Heng L; Xiao C; Shunan W; Yu G; Weiguo Z
Acta Radiol; 2017 Sep; 58(9):1138-1146. PubMed ID: 27956462
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging for monitoring the anti-angiogenesis efficacy in a C6 glioma rat model.
Hou W; Li X; Pan H; Xu M; Bi S; Shen Y; Yu Y
Acta Radiol; 2020 Jul; 61(7):973-982. PubMed ID: 31739674
[TBL] [Abstract][Full Text] [Related]
6. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
[TBL] [Abstract][Full Text] [Related]
7. Characterization of xanthatin: anticancer properties and mechanisms of inhibited murine melanoma in vitro and in vivo.
Li WD; Wu Y; Zhang L; Yan LG; Yin FZ; Ruan JS; Chen ZP; Yang GM; Yan CP; Zhao D; Lu Y; Cai BC
Phytomedicine; 2013 Jul; 20(10):865-73. PubMed ID: 23664560
[TBL] [Abstract][Full Text] [Related]
8. Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy.
Dominietto M; Dobosz M; Bürgi S; Renner A; Zahlmann G; Scheuer W; Rudin M
Eur Radiol; 2017 Jul; 27(7):2894-2902. PubMed ID: 27830379
[TBL] [Abstract][Full Text] [Related]
9. DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model.
Hoff BA; Bhojani MS; Rudge J; Chenevert TL; Meyer CR; Galbán S; Johnson TD; Leopold JS; Rehemtulla A; Ross BD; Galbán CJ
NMR Biomed; 2012 Jul; 25(7):935-42. PubMed ID: 22190279
[TBL] [Abstract][Full Text] [Related]
10. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.
Sun C; Yu Y; Wang L; Wu B; Xia L; Feng F; Ling Z; Wang S
J Exp Clin Cancer Res; 2016 Feb; 35():32. PubMed ID: 26872471
[TBL] [Abstract][Full Text] [Related]
11. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
[TBL] [Abstract][Full Text] [Related]
13. Quantitative in vivo imaging of tissue factor expression in glioma using dynamic contrast-enhanced MRI derived parameters.
Chen X; Xie T; Fang J; Xue W; Tong H; Kang H; Wang S; Yang Y; Xu M; Zhang W
Eur J Radiol; 2017 Aug; 93():236-242. PubMed ID: 28668420
[TBL] [Abstract][Full Text] [Related]
14. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
[TBL] [Abstract][Full Text] [Related]
16. Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting.
Hamans B; Navis AC; Wright A; Wesseling P; Heerschap A; Leenders W
Neuro Oncol; 2013 Dec; 15(12):1615-24. PubMed ID: 24158109
[TBL] [Abstract][Full Text] [Related]
17. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
18. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
19. A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model.
Luo Y; Jiang F; Cole TB; Hradil VP; Reuter D; Chakravartty A; Albert DH; Davidsen SK; Cox BF; McKeegan EM; Fox GB
Cancer Chemother Pharmacol; 2012 Apr; 69(4):911-21. PubMed ID: 22080168
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?
Little RA; Barjat H; Hare JI; Jenner M; Watson Y; Cheung S; Holliday K; Zhang W; O'Connor JPB; Barry ST; Puri S; Parker GJM; Waterton JC
Magn Reson Imaging; 2018 Feb; 46():98-105. PubMed ID: 29154898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
